Uncovering the Potential of CD19 CAR-Tregs: Pre- Clinical Data Driving the Next Wave of Treg Therapies

• Evaluate CD19 CAR-Treg design, function, and in preliminary data
• Understand how pre-clinical results inform translational and clinical readiness

Speakers:

Jenny McGovern

Senior Director Cellular Immunology

Quell Therapeutics